Weighted gene co‐expression network analysis and machine learning identified the lipid metabolism‐related gene LGMN as a novel biomarker for keloid
Experimental Dermatology · 2024
DOI: 10.1111/exd.14974 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2024. Verfasst von Qirui Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Lipid Metabolism, Keloid, Cysteine Endopeptidases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Clinical Research Center for Plastic and Reconstruction Surgery.
Abstract (Originalsprache)
The aetiology of keloid formation remains unclear, and existing treatment modalities have not definitively established a successful approach. Therefore, it is necessary to identify reliable and novel keloid biomarkers as potential targets for therapeutic interventions. In this study, we performed differential expression analysis and functional enrichment analysis on the keloid related datasets, and found that multiple metabolism‐related pathways were associated with keloid formation. Subsequently, the differentially expressed genes (DEGs) were intersected with the results of weighted gene co‐expression network analysis (WGCNA) and the lipid metabolism‐related genes (LMGs). Then, three learning machine algorithms (SVM‐RFE, LASSO and Random Forest) together identified legumain (LGMN) as the most critical LMGs. LGMN was overexpressed in keloid and had a high diagnostic performance. The protein–protein interaction (PPI) network related to LGMN was constructed by GeneMANIA database. Functional analysis of indicated PPI network was involved in multiple immune response‐related biological processes. Furthermore, immune infiltration analysis was conducted using the CIBERSORT method. M2‐type macrophages were highly infiltrated in keloid tissues and were found to be significantly and positively correlated with LGMN expression. Gene set variation analysis (GSVA) indicated that LGMN may be related to promoting fibroblast proliferation and inhibiting their apoptosis. Moreover, eight potential drug candidates for keloid treatment were predicted by the DSigDB database. Western blot, qRT‐PCR and immunohistochemistry staining results confirmed that LGMN was highly expressed in keloid. Collectively, our findings may identify a new biomarker and therapeutic target for keloid and contribute to the understanding of the potential pathogenesis of keloid.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Key Laboratory of Stomatology, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Department of Orthodontics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University S…
ORCID-Profile: Renpeng Zhou, Danru Wang
Förderung
- National Natural Science Foundation of China
- Shanghai Clinical Research Center for Plastic and Reconstruction Surgery
Zitieren
APA
Wang, Q., Huang, X., Zeng, S., Zhou, R., & Wang, D. (2024). Weighted gene co‐expression network analysis and machine learning identified the lipid metabolism‐related gene LGMN as a novel biomarker for keloid. Experimental Dermatology. https://doi.org/10.1111/exd.14974
Vancouver
Wang Q, Huang X, Zeng S, Zhou R, Wang D. Weighted gene co‐expression network analysis and machine learning identified the lipid metabolism‐related gene LGMN as a novel biomarker for keloid. Experimental Dermatology. 2024. doi:10.1111/exd.14974
BibTeX
@article{Wang2024,
author = {Wang, Qirui and Huang, Xingtai and Zeng, Siyi and Zhou, Renpeng and Wang, Danru},
title = {Weighted gene co‐expression network analysis and machine learning identified the lipid metabolism‐related gene LGMN as a novel biomarker for keloid},
journal = {Experimental Dermatology},
year = {2024},
doi = {10.1111/exd.14974}
}
EUVIMED